Publications on HIV PDR in the Southern Cone, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the whole LAC region. by Santiago Avila-Rios (3160959)

Subjects:

Publications on HIV PDR in the Caribbean, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Limited field radiation therapy results in decreased bone fracture toughness in a murine model by Christopher M. Bartlow (5814998)

“…To explore this phenomenon, a mouse model (BALB/cJ) of fractionated, limited field, bilateral hindlimb irradiation (4x5 Gy) was used. …”

TIMP3 overexpression decreases tibial bone mechanical properties from macroscale to nanoscale mechanics. by Blandine Poulet (2939877)

“…<p>A, Von Kossa staining of tibia epiphysis and metaphysis of WT and TIMP3 Tg/Tg mice showed decreased trabecular bone in TIMP3 Tg/Tg mice (Magnification x2). …”

Decrease in fecundity with <i>PPR</i>. by Corinne Vacher (272363)

Inhibition of calcineurin activity increased GluA1 surface trafficking by phosphorylation but decreases calcineurin. by Seonil Kim (591039)

PF treatment decreases the levels of IL-1β(A) and TNFα(B) in plasma. by Ruo-Bing Guo (298949)

CaA decreases the CSCs-like properties of malignant HaCaT cells by p38. by Ye Yang (297214)

DataSheet2_WNT5A Interacts With FZD5 and LRP5 to Regulate Proliferation and Self-Renewal of Endometrial Mesenchymal Stem-Like Cells.docx by Tianqi Li (1335987)

“…Since WNT5A-responsive mechanisms on eMSC are still uncertain, we hypothesize that the WNT ligand–WNT5A works to activate WNT/β-catenin signaling through binding to Frizzled receptors (FZDs) and co-receptor low-density lipoprotein receptor-related protein 5 (LRP5). …”

DataSheet1_WNT5A Interacts With FZD5 and LRP5 to Regulate Proliferation and Self-Renewal of Endometrial Mesenchymal Stem-Like Cells.docx by Tianqi Li (1335987)

“…Since WNT5A-responsive mechanisms on eMSC are still uncertain, we hypothesize that the WNT ligand–WNT5A works to activate WNT/β-catenin signaling through binding to Frizzled receptors (FZDs) and co-receptor low-density lipoprotein receptor-related protein 5 (LRP5). …”

DataSheet2_WNT5A Interacts With FZD5 and LRP5 to Regulate Proliferation and Self-Renewal of Endometrial Mesenchymal Stem-Like Cells.docx by Tianqi Li (1335987)

“…Since WNT5A-responsive mechanisms on eMSC are still uncertain, we hypothesize that the WNT ligand–WNT5A works to activate WNT/β-catenin signaling through binding to Frizzled receptors (FZDs) and co-receptor low-density lipoprotein receptor-related protein 5 (LRP5). …”

DataSheet1_WNT5A Interacts With FZD5 and LRP5 to Regulate Proliferation and Self-Renewal of Endometrial Mesenchymal Stem-Like Cells.docx by Tianqi Li (1335987)

“…Since WNT5A-responsive mechanisms on eMSC are still uncertain, we hypothesize that the WNT ligand–WNT5A works to activate WNT/β-catenin signaling through binding to Frizzled receptors (FZDs) and co-receptor low-density lipoprotein receptor-related protein 5 (LRP5). …”

Overexpression of DHCR24 on the cell surface of HCC cell lines was decreased by treatment with U18666A and cyclosporin A. by Makoto Saito (721667)

Rank importance, where impairment at a point has a significant association with decreased vision-related quality of life. by Hiroshi Murata (387321)

Studies exploring a relationship between <i>Shigella</i> infection and decreased linear growth/stunting or growth measures in young children and other relevant outcomes. by Karoun H. Bagamian (8911211)

The m⁶A peak of 3’UTR of TLR4 mRNA decreases significantly in METTL14-knockdown PK-15 cells. by Jing Chen (4762)

Increasing cell density beyond a threshold decreases both cell survival and VEGF secretion. by Rachel Coy (4027016)

Enhanced IDO and a decreased PD-L1 expression in NOD pancreas pDCs. by Jojanneke M. C. Welzen-Coppens (287113)

Chemically inhibiting LDHA or PDK1 decreases cell viability in Aβ resistant cells. by Jordan T. Newington (223389)

“…Similarly, 48 hr Aβ exposure significantly decreased cell viability in both PC12 (<b>C</b>) and B12 (<b>D</b>) resistant lines when cells were co-treated with 2.5 mM dichloroacetate (DCA), a chemical inhibitor of PDK1 (*P<0.01). …”